Anti-S IgG Seroresponses changed from baseline after vaccination;Frequency of all unsolicited AEs;Frequency of SAEs;Frequency of solicited reportable local adverse event after vaccination;Frequency of solicited reportable systemic adverse event after vaccination;GMFR changed from baseline in anti-S IgG GMT after vaccination;GMFR changed from baseline in NT50 against SARS-CoV-2 pseudovirus after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at baseline and after vaccination;GMT Anti-S IgG at baseline and after vaccination

Anti-S IgG Seroresponses changed from baseline after vaccination;Frequency of all unsolicited AEs;Frequency of SAEs;Frequency of solicited reportable local adverse event after vaccination;Frequency of solicited reportable systemic adverse event after vaccination;GMFR changed from baseline in anti-S IgG GMT after vaccination;GMFR changed from baseline in NT50 against SARS-CoV-2 pseudovirus after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at baseline and after vaccination;GMT Anti-S IgG at baseline and after vaccination

Anti-S IgG Seroresponses changed from baseline at 28 days after vaccination;Anti-S IgG Seroresponses changed from baseline at 60 days after vaccination;Anti-S IgG Seroresponses changed from baseline at 90 days after vaccination;Frequency of all unsolicited AEs;Frequency of SAEs;Frequency of solicited reportable local adverse event after vaccination;Frequency of solicited reportable systemic adverse event after vaccination;GMFR changed from baseline in anti-S IgG GMT at 28 days after vaccination;GMFR changed from baseline in anti-S IgG GMT at 60 days after vaccination;GMFR changed from baseline in anti-S IgG GMT at 90 days after vaccination;GMFR changed from baseline in NT50 against SARS-CoV-2 pseudovirus at 28 days after vaccination;GMFR changed from baseline in NT50 against SARS-CoV-2 pseudovirus at 90 days after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at 28 days after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at 90 days after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at baseline;GMT Anti-S IgG at 28 days after vaccination;GMT Anti-S IgG at 60 days after vaccination;GMT Anti-S IgG at 90 days after vaccination;GMT Anti-S IgG at baseline;NT50 seroresponses against SARS-CoV-2 pseudovirus changed from baseline at 28 days after vaccination;NT50 seroresponses against SARS-CoV-2 pseudovirus changed from baseline at 90 days after vaccination

Anti-S IgG Seroresponses changed from baseline at 28 days after vaccination;Anti-S IgG Seroresponses changed from baseline at 60 days after vaccination;Anti-S IgG Seroresponses changed from baseline at 90 days after vaccination;Frequency of all unsolicited AEs;Frequency of SAEs;Frequency of solicited reportable local adverse event after vaccination;Frequency of solicited reportable systemic adverse event after vaccination;GMFR changed from baseline in anti-S IgG GMT at 28 days after vaccination;GMFR changed from baseline in anti-S IgG GMT at 60 days after vaccination;GMFR changed from baseline in anti-S IgG GMT at 90 days after vaccination;GMFR changed from baseline in NT50 against SARS-CoV-2 pseudovirus at 28 days after vaccination;GMFR changed from baseline in NT50 against SARS-CoV-2 pseudovirus at 90 days after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at 28 days after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at 90 days after vaccination;GMT against SARS-Cov-2 pseudovirus (PVNT) Neutralizing antibody titer 50 at baseline;GMT Anti-S IgG at 28 days after vaccination;GMT Anti-S IgG at 60 days after vaccination;GMT Anti-S IgG at 90 days after vaccination;GMT Anti-S IgG at baseline;NT50 seroresponses against SARS-CoV-2 pseudovirus changed from baseline at 28 days after vaccination;NT50 seroresponses against SARS-CoV-2 pseudovirus changed from baseline at 90 days after vaccination